12:00 AM
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lymphoseek tilmanocept regulatory update

Navidea said it resubmitted an NDA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. The company...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >